Cancer is of course one of the most challenging pathologies patients and doctors can face; the disease cells are fiendishly adaptive as the body...
Despite the recent slump, the life sciences sector - which includes biotech - offers investors some of the best long-term opportunities for...
Biotech stocks have stalled in 2016 along with the broader markets, with the iShares Nasdaq Biotech ETF (Nasdaq: IBB) down 24.43% year to...
Biotech is in the midst of its longest bull run in history, and there's every reason to expect it will remain an attractive outperformer this...
As you might expect, my email's been flooded with all kinds of questions, comments, and observations since the markets began their 7% slide...
The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.
In fact,...
With a net worth of $12.6 billion, Patrick Soon-Shiong, MD, is the world's richest doctor, the richest American in the healthcare industry, and...
Over the past six months, we've seen the Nasdaq Biotechnology Index, an indicator for the entire sector, take some wild swings ...
For biotech stock investors, what happened to Aquanox Pharmaceuticals Inc. (Nasdaq: AQXP) over the past week looked like the ultimate fantasy come...
Medical device companies can be profit-making machines - one manufacturer of magnetic resonance imaging (MRI) machines and other high-tech...
Back on March 27, 2014, I recommended that Money Morning Members pick up what I felt was the very best play in the...
Editor's Note: Normally this intelligence would go to paid-up members of Bill's Private Briefing, but this debut is going to be so big, and the...
Prescription drug spending continues to hit record highs, and the world's top pharma companies continue to bank billions.
More than $374...
On Jan. 7, 2015, CytRX Corp. announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and...
Biotech stocks have seriously outperformed the markets in 2015, and our favorite biotech ETF has been one of the biggest winners. In...
No one is thrilled with the way new drugs and medical devices come to market in the U.S. - not the biotech and pharmaceutical...
Biotech investing can be tricky. The industry is complicated, and the stocks are volatile.
But the profit payoff can be life-changing....
The biotech market has sold off last week, with the Nasdaq Biotechnology Index dropping 6.4% since April 23. And because of that, some of the...
There are great companies, and there are companies that do great things in the marketplace... and for your health.
The...
Wall Street pundits are claiming we are on the precipice of a biotech bubble because biotechnology stocks have been soaring. The Nasdaq...
